key: cord-1039439-x34acp2v
authors: Callahan, Sean J.; Harris, Dixie; Collingridge, Dave S.; Guidry, David W.; Dean, Nathan C.; Lanspa, Michael J.; Blagev, Denitza P.
title: Diagnosing EVALI in the Time of COVID-19
date: 2020-06-26
journal: Chest
DOI: 10.1016/j.chest.2020.06.029
sha: c0a93a31a0832ffcc61cf9e5e89e16020160129c
doc_id: 1039439
cord_uid: x34acp2v

nan

In 2019 the United States experienced an outbreak of respiratory illnesses associated 12 with electronic cigarette use. E-cigarette, or vaping, product use-associated lung injury 13 (EVALI) resulted in over 2800 hospitalizations and 68 deaths, but numbers have 14 dwindled recently 1 . This decline may relate to a decrease in high-risk products, Twelve patients met inclusion criteria, eleven of whom met Centers for Disease Control 32 criteria for "confirmed" EVALI and one "probable". Our findings align with previous 33 reports 5,6 : patients were predominantly young (mean age 30.8, range 18 to 53), 

Vaping-related Acute Parenchymal Lung Injury: A Systematic 126 Review

Clinical Characteristics of 138 Hospitalized Patients 128 With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Radiological findings from 81 patients with COVID-131 19 pneumonia in Wuhan, China: a descriptive study. The Lancet Infectious 132 Diseases

Clinical 134 presentation, treatment, and short-term outcomes of lung injury

e-cigarettes or vaping: a prospective observational cohort study

Pulmonary Illness Related to E-Cigarette Use 138

in Illinois and Wisconsin -Final Report

Lung Injuries Associated with Use of Vaping Products

Diagnosis of EVALI: 144 General Approach and the Role of Bronchoscopy

Clinical Characteristics of Coronavirus Disease 146 2019 in China

America Guidelines on the Treatment and Management of Patients with COVID-149 19

EVALI: E-cigarette, or vaping, product use-associated lung injury HFNC: high-flow nasal cannula ICU: Intensive Care Unit IgG: immunoglobulin G MV: invasive mechanical ventilation NC: nasal cannula NIPPV: non-invasive

This manuscript is not under consideration at other journals. Dr. Callahan takes responsibility for the integrity of the work as a whole.